Sarepta Therapeutics (United States)
In research, Sarepta Therapeutics (United States) stands highest in Life Sciences (#8,203 of 14,347 worldwide) and Biochemistry, Genetics and Molecular Biology (#6,600 of 7,814 worldwide), over all time. Relative to its size it is most specialised in Molecular Biology and Biochemistry, Genetics and Molecular Biology — Molecular Biology is 9.8× its share of world research.
- World rank, 2022–2025
- #22,425 of 28,054 · #18,070 all time
- Rank in United States
- #3,326 of 4,192
- Research works
- 314 ▲ 123% vs 2013–17
- Citations
- 11k 33.6 per fractional work
- Top-10% rate
- 11.0% record average 16.5%
- Open access
- 41% world 28%
What is Sarepta Therapeutics (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #8,203 of 14,347 | 23.0% | 161 | |
| Biochemistry, Genetics and Molecular BiologyField | #6,600 of 7,814 | 21.7% | 136 |
Each strip is that field’s whole ranked pool, with the notch where Sarepta Therapeutics (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Sarepta Therapeutics (United States) specialise in?
Where its research is concentrated relative to its size: Molecular Biology takes 9.8× the share of its output that it takes of world research.
- Molecular BiologySubfield · 32.8 works9.8×
- Biochemistry, Genetics and Molecular BiologyField · 42.9 works7.3×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.3×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 7.3×
- Chemistry 2.6×
- Economics, Econometrics and Finance 2.4×
- Medicine 1.8×
- Veterinary 1.8×
- Immunology and Microbiology 1.6×
- Neuroscience 1.1×
- Pharmacology, Toxicology and Pharmaceutics 1.1×
- Mathematics 0.8×
- Business, Management and Accounting 0.4×
- Decision Sciences 0.4×
- Nursing 0.4×
- Health Professions 0.3×
- Engineering 0.2×
- Psychology 0.2×
- Social Sciences 0.2×
- Materials Science 0.2×
- Earth and Planetary Sciences 0.1×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Environmental Science 0.1×
Who are the top researchers at Sarepta Therapeutics (United States)?
Ranked on the composite score, Patrick L. Iversen and Katherine Gooch lead among researchers whose main affiliation is Sarepta Therapeutics (United States).
- 1 Patrick L. Iversen United States · #296,662 worldwide 183 citations · 55 works
- 2 Katherine Gooch United States · #1,403,675 worldwide 20 citations · 27 works
Which keywords describe research at Sarepta Therapeutics (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Stem Cells, Muscle Regeneration, Skeletal Muscle Atrophy, Gene Therapy, Regenerative Medicine, Genomic Integration, Cost-effectiveness Analysis and Health Utility Measures.
- siRNA Delivery
- RNA Interference
- Protein Arginine Methyltransferases
- Epigenetic Regulation
- Exoskeletons
- Transcriptional Regulation
- Chimeric Antigen Receptor
- Genetic Mutations
- Spinal Muscular Atrophy
- Neuromuscular Junction
- Immunotherapy
- Regulatory Challenges
- Translational Research
- Viral Vectors
- Health Utility Measures
- Treatment
- Clinical Trials
- Regenerative Medicine
- Epidemiology
- Muscle Regeneration
- Stem Cells
- Skeletal Muscle Atrophy
- Gene Therapy
- Genomic Integration
- Quality of Life
- Cost-effectiveness Analysis
- AAV
- Patient Safety
- Antisense Oligonucleotides
- Stem Cell Regulation
- Rehabilitation
- SMN1
- Cancer Immunotherapy
- CAR T Cells
- Gene Expression
- Mitochondrial Dysfunction
- Lower Limb
- Arginine Methylation
- Protein Aggregation
- Urolithiasis
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Stem Cells20▲ 70×2 topics
- Muscle Regeneration20▲ 666×1 topic
- Skeletal Muscle Atrophy20▲ 666×1 topic
- Epidemiology7▲ 1.51×24 topics
- Gene Therapy6▲ 29×3 topics
- Regenerative Medicine5▲ 18×3 topics
- Genomic Integration5▲ 74×2 topics
- Clinical Trials5▲ 6.2×6 topics
- Quality of Life5▲ 2.9×6 topics
- Treatment4▲ 3.3×12 topics
- Cost-effectiveness Analysis4▲ 45×1 topic
- Health Utility Measures4▲ 45×1 topic
- AAV4▲ 95×1 topic
- Viral Vectors4▲ 95×1 topic
- Patient Safety4▲ 25×3 topics
- Translational Research4▲ 104×2 topics
- Antisense Oligonucleotides4▲ 86×2 topics
- Regulatory Challenges4▲ 41×1 topic
- Stem Cell Regulation4▲ 160×1 topic
- Immunotherapy4▲ 5.0×6 topics
- Rehabilitation4▲ 8.7×3 topics
- Neuromuscular Junction4▲ 79×2 topics
- SMN14▲ 146×1 topic
- Spinal Muscular Atrophy4▲ 146×1 topic
- Cancer Immunotherapy3▲ 20×2 topics
- Genetic Mutations3▲ 7.1×7 topics
- CAR T Cells3▲ 39×1 topic
- Chimeric Antigen Receptor3▲ 39×1 topic
- Gene Expression3▲ 4.1×7 topics
- Transcriptional Regulation3▲ 15×3 topics
- Mitochondrial Dysfunction3▲ 8.2×6 topics
- Exoskeletons2▲ 72×1 topic
- Lower Limb2▲ 72×1 topic
- Epigenetic Regulation2▲ 9.8×2 topics
- Arginine Methylation2▲ 67×1 topic
- Protein Arginine Methyltransferases2▲ 67×1 topic
- Protein Aggregation2▲ 30×2 topics
- RNA Interference2▲ 18×1 topic
- Urolithiasis2▲ 64×1 topic
- siRNA Delivery2▲ 26×1 topic
Which research topics does Sarepta Therapeutics (United States) publish most on?
By volume in 2022–2025: Muscle Physiology and Disorders, Health Systems, Economic Evaluations, Quality of Life, Virus-based gene therapy research and Biomedical Ethics and Regulation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Muscle Physiology and Disorders Molecular Biology 20 works
- 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
- 3 Virus-based gene therapy research Genetics 4 works
- 4 Biomedical Ethics and Regulation Physiology 4 works
- 5 Neurogenetic and Muscular Disorders Research Genetics 4 works
- 6 CAR-T cell therapy research Oncology 3 works
- 7 Prosthetics and Rehabilitation Robotics Biomedical Engineering 2 works
- 8 Cancer-related gene regulation Molecular Biology 2 works
- 9 Kidney Stones and Urolithiasis Treatments Pulmonary and Respiratory Medicine 2 works
- 10 RNA Interference and Gene Delivery Molecular Biology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Sarepta Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 123% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- Center for Astrophysics Harvard & Smithsonian
- National Bureau of Economic Research
- IIT@MIT
- World Wide Web Consortium
- Broad Institute
- Smithsonian Astrophysical Observatory
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.